1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Membranes for Guided Tissue and Bone Regeneration Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Membranes for Guided Tissue and Bone Regeneration by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Membranes for Guided Tissue and Bone Regeneration by Country/Region, 2018, 2022 & 2029
2.2 Membranes for Guided Tissue and Bone Regeneration Segment by Type
2.2.1 Absorbable Membrane
2.2.2 Non-resorbable Membrane
2.3 Membranes for Guided Tissue and Bone Regeneration Sales by Type
2.3.1 Global Membranes for Guided Tissue and Bone Regeneration Sales Market Share by Type (2018-2023)
2.3.2 Global Membranes for Guided Tissue and Bone Regeneration Revenue and Market Share by Type (2018-2023)
2.3.3 Global Membranes for Guided Tissue and Bone Regeneration Sale Price by Type (2018-2023)
2.4 Membranes for Guided Tissue and Bone Regeneration Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Dental
2.4.4 Other
2.5 Membranes for Guided Tissue and Bone Regeneration Sales by Application
2.5.1 Global Membranes for Guided Tissue and Bone Regeneration Sale Market Share by Application (2018-2023)
2.5.2 Global Membranes for Guided Tissue and Bone Regeneration Revenue and Market Share by Application (2018-2023)
2.5.3 Global Membranes for Guided Tissue and Bone Regeneration Sale Price by Application (2018-2023)
3 Global Membranes for Guided Tissue and Bone Regeneration by Company
3.1 Global Membranes for Guided Tissue and Bone Regeneration Breakdown Data by Company
3.1.1 Global Membranes for Guided Tissue and Bone Regeneration Annual Sales by Company (2018-2023)
3.1.2 Global Membranes for Guided Tissue and Bone Regeneration Sales Market Share by Company (2018-2023)
3.2 Global Membranes for Guided Tissue and Bone Regeneration Annual Revenue by Company (2018-2023)
3.2.1 Global Membranes for Guided Tissue and Bone Regeneration Revenue by Company (2018-2023)
3.2.2 Global Membranes for Guided Tissue and Bone Regeneration Revenue Market Share by Company (2018-2023)
3.3 Global Membranes for Guided Tissue and Bone Regeneration Sale Price by Company
3.4 Key Manufacturers Membranes for Guided Tissue and Bone Regeneration Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Membranes for Guided Tissue and Bone Regeneration Product Location Distribution
3.4.2 Players Membranes for Guided Tissue and Bone Regeneration Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Membranes for Guided Tissue and Bone Regeneration by Geographic Region
4.1 World Historic Membranes for Guided Tissue and Bone Regeneration Market Size by Geographic Region (2018-2023)
4.1.1 Global Membranes for Guided Tissue and Bone Regeneration Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Membranes for Guided Tissue and Bone Regeneration Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Membranes for Guided Tissue and Bone Regeneration Market Size by Country/Region (2018-2023)
4.2.1 Global Membranes for Guided Tissue and Bone Regeneration Annual Sales by Country/Region (2018-2023)
4.2.2 Global Membranes for Guided Tissue and Bone Regeneration Annual Revenue by Country/Region (2018-2023)
4.3 Americas Membranes for Guided Tissue and Bone Regeneration Sales Growth
4.4 APAC Membranes for Guided Tissue and Bone Regeneration Sales Growth
4.5 Europe Membranes for Guided Tissue and Bone Regeneration Sales Growth
4.6 Middle East & Africa Membranes for Guided Tissue and Bone Regeneration Sales Growth
5 Americas
5.1 Americas Membranes for Guided Tissue and Bone Regeneration Sales by Country
5.1.1 Americas Membranes for Guided Tissue and Bone Regeneration Sales by Country (2018-2023)
5.1.2 Americas Membranes for Guided Tissue and Bone Regeneration Revenue by Country (2018-2023)
5.2 Americas Membranes for Guided Tissue and Bone Regeneration Sales by Type
5.3 Americas Membranes for Guided Tissue and Bone Regeneration Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Membranes for Guided Tissue and Bone Regeneration Sales by Region
6.1.1 APAC Membranes for Guided Tissue and Bone Regeneration Sales by Region (2018-2023)
6.1.2 APAC Membranes for Guided Tissue and Bone Regeneration Revenue by Region (2018-2023)
6.2 APAC Membranes for Guided Tissue and Bone Regeneration Sales by Type
6.3 APAC Membranes for Guided Tissue and Bone Regeneration Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Membranes for Guided Tissue and Bone Regeneration by Country
7.1.1 Europe Membranes for Guided Tissue and Bone Regeneration Sales by Country (2018-2023)
7.1.2 Europe Membranes for Guided Tissue and Bone Regeneration Revenue by Country (2018-2023)
7.2 Europe Membranes for Guided Tissue and Bone Regeneration Sales by Type
7.3 Europe Membranes for Guided Tissue and Bone Regeneration Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Membranes for Guided Tissue and Bone Regeneration by Country
8.1.1 Middle East & Africa Membranes for Guided Tissue and Bone Regeneration Sales by Country (2018-2023)
8.1.2 Middle East & Africa Membranes for Guided Tissue and Bone Regeneration Revenue by Country (2018-2023)
8.2 Middle East & Africa Membranes for Guided Tissue and Bone Regeneration Sales by Type
8.3 Middle East & Africa Membranes for Guided Tissue and Bone Regeneration Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Membranes for Guided Tissue and Bone Regeneration
10.3 Manufacturing Process Analysis of Membranes for Guided Tissue and Bone Regeneration
10.4 Industry Chain Structure of Membranes for Guided Tissue and Bone Regeneration
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Membranes for Guided Tissue and Bone Regeneration Distributors
11.3 Membranes for Guided Tissue and Bone Regeneration Customer
12 World Forecast Review for Membranes for Guided Tissue and Bone Regeneration by Geographic Region
12.1 Global Membranes for Guided Tissue and Bone Regeneration Market Size Forecast by Region
12.1.1 Global Membranes for Guided Tissue and Bone Regeneration Forecast by Region (2024-2029)
12.1.2 Global Membranes for Guided Tissue and Bone Regeneration Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Membranes for Guided Tissue and Bone Regeneration Forecast by Type
12.7 Global Membranes for Guided Tissue and Bone Regeneration Forecast by Application
13 Key Players Analysis
13.1 Geistlich Pharma
13.1.1 Geistlich Pharma Company Information
13.1.2 Geistlich Pharma Membranes for Guided Tissue and Bone Regeneration Product Portfolios and Specifications
13.1.3 Geistlich Pharma Membranes for Guided Tissue and Bone Regeneration Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Geistlich Pharma Main Business Overview
13.1.5 Geistlich Pharma Latest Developments
13.2 Keystone Dental
13.2.1 Keystone Dental Company Information
13.2.2 Keystone Dental Membranes for Guided Tissue and Bone Regeneration Product Portfolios and Specifications
13.2.3 Keystone Dental Membranes for Guided Tissue and Bone Regeneration Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Keystone Dental Main Business Overview
13.2.5 Keystone Dental Latest Developments
13.3 Yantai Zhenghai Bio-tech
13.3.1 Yantai Zhenghai Bio-tech Company Information
13.3.2 Yantai Zhenghai Bio-tech Membranes for Guided Tissue and Bone Regeneration Product Portfolios and Specifications
13.3.3 Yantai Zhenghai Bio-tech Membranes for Guided Tissue and Bone Regeneration Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Yantai Zhenghai Bio-tech Main Business Overview
13.3.5 Yantai Zhenghai Bio-tech Latest Developments
13.4 Bio-tech
13.4.1 Bio-tech Company Information
13.4.2 Bio-tech Membranes for Guided Tissue and Bone Regeneration Product Portfolios and Specifications
13.4.3 Bio-tech Membranes for Guided Tissue and Bone Regeneration Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Bio-tech Main Business Overview
13.4.5 Bio-tech Latest Developments
13.5 Genoss
13.5.1 Genoss Company Information
13.5.2 Genoss Membranes for Guided Tissue and Bone Regeneration Product Portfolios and Specifications
13.5.3 Genoss Membranes for Guided Tissue and Bone Regeneration Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Genoss Main Business Overview
13.5.5 Genoss Latest Developments
13.6 MegaGen Impant
13.6.1 MegaGen Impant Company Information
13.6.2 MegaGen Impant Membranes for Guided Tissue and Bone Regeneration Product Portfolios and Specifications
13.6.3 MegaGen Impant Membranes for Guided Tissue and Bone Regeneration Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 MegaGen Impant Main Business Overview
13.6.5 MegaGen Impant Latest Developments
13.7 Sunstar
13.7.1 Sunstar Company Information
13.7.2 Sunstar Membranes for Guided Tissue and Bone Regeneration Product Portfolios and Specifications
13.7.3 Sunstar Membranes for Guided Tissue and Bone Regeneration Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Sunstar Main Business Overview
13.7.5 Sunstar Latest Developments
13.8 OraPharma
13.8.1 OraPharma Company Information
13.8.2 OraPharma Membranes for Guided Tissue and Bone Regeneration Product Portfolios and Specifications
13.8.3 OraPharma Membranes for Guided Tissue and Bone Regeneration Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 OraPharma Main Business Overview
13.8.5 OraPharma Latest Developments
13.9 Biomedical Tissues
13.9.1 Biomedical Tissues Company Information
13.9.2 Biomedical Tissues Membranes for Guided Tissue and Bone Regeneration Product Portfolios and Specifications
13.9.3 Biomedical Tissues Membranes for Guided Tissue and Bone Regeneration Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Biomedical Tissues Main Business Overview
13.9.5 Biomedical Tissues Latest Developments
13.10 Botiss
13.10.1 Botiss Company Information
13.10.2 Botiss Membranes for Guided Tissue and Bone Regeneration Product Portfolios and Specifications
13.10.3 Botiss Membranes for Guided Tissue and Bone Regeneration Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Botiss Main Business Overview
13.10.5 Botiss Latest Developments
13.11 Dentsply Sirona
13.11.1 Dentsply Sirona Company Information
13.11.2 Dentsply Sirona Membranes for Guided Tissue and Bone Regeneration Product Portfolios and Specifications
13.11.3 Dentsply Sirona Membranes for Guided Tissue and Bone Regeneration Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Dentsply Sirona Main Business Overview
13.11.5 Dentsply Sirona Latest Developments
13.12 Zimmer Biomet
13.12.1 Zimmer Biomet Company Information
13.12.2 Zimmer Biomet Membranes for Guided Tissue and Bone Regeneration Product Portfolios and Specifications
13.12.3 Zimmer Biomet Membranes for Guided Tissue and Bone Regeneration Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Zimmer Biomet Main Business Overview
13.12.5 Zimmer Biomet Latest Developments
13.13 Lynch Biologics
13.13.1 Lynch Biologics Company Information
13.13.2 Lynch Biologics Membranes for Guided Tissue and Bone Regeneration Product Portfolios and Specifications
13.13.3 Lynch Biologics Membranes for Guided Tissue and Bone Regeneration Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Lynch Biologics Main Business Overview
13.13.5 Lynch Biologics Latest Developments
13.14 Neoss Limited
13.14.1 Neoss Limited Company Information
13.14.2 Neoss Limited Membranes for Guided Tissue and Bone Regeneration Product Portfolios and Specifications
13.14.3 Neoss Limited Membranes for Guided Tissue and Bone Regeneration Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Neoss Limited Main Business Overview
13.14.5 Neoss Limited Latest Developments
13.15 Biomatlante
13.15.1 Biomatlante Company Information
13.15.2 Biomatlante Membranes for Guided Tissue and Bone Regeneration Product Portfolios and Specifications
13.15.3 Biomatlante Membranes for Guided Tissue and Bone Regeneration Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Biomatlante Main Business Overview
13.15.5 Biomatlante Latest Developments
13.16 Nobel Biocare Services/Danaher Corporation
13.16.1 Nobel Biocare Services/Danaher Corporation Company Information
13.16.2 Nobel Biocare Services/Danaher Corporation Membranes for Guided Tissue and Bone Regeneration Product Portfolios and Specifications
13.16.3 Nobel Biocare Services/Danaher Corporation Membranes for Guided Tissue and Bone Regeneration Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Nobel Biocare Services/Danaher Corporation Main Business Overview
13.16.5 Nobel Biocare Services/Danaher Corporation Latest Developments
13.17 Salvin Dental Specialties，Inc
13.17.1 Salvin Dental Specialties，Inc Company Information
13.17.2 Salvin Dental Specialties，Inc Membranes for Guided Tissue and Bone Regeneration Product Portfolios and Specifications
13.17.3 Salvin Dental Specialties，Inc Membranes for Guided Tissue and Bone Regeneration Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Salvin Dental Specialties，Inc Main Business Overview
13.17.5 Salvin Dental Specialties，Inc Latest Developments
14 Research Findings and Conclusion
| ※参考情報 組織＆骨再生誘導用膜（Guided Tissue and Bone Regeneration Membranes）とは、歯科および外科の分野で使用される特殊な材料であり、主に歯周組織や骨の再生を誘導するために設計されています。これらの膜は、損傷した組織や骨の修復を促進するために、特定の生物学的環境を提供します。膜の使用は、組織工学や再生医療の進展により、患者に対する治療効果を向上させるための重要な手法となっています。 まず、組織＆骨再生誘導用膜の定義について説明します。これらの膜は、主に生体適合性材料で構成されており、特定の部位での細胞の移動を制限し、特定の組織が再生するための環境を提供します。組織再生には、血管化、細胞の浸潤、そして新たな組織の形成が必要であり、再生誘導膜はこれらの過程を助ける役割を果たします。 次に、特徴について詳しく見ていきましょう。組織＆骨再生誘導用膜の主な特徴は、以下のようなものです。まず、生体適合性です。膜は、体内で拒絶反応を引き起こさず、組織と良好に適合することが求められます。次に、バイオ活性です。膜は、細胞の増殖や分化を促進する成分を含むことが望ましいです。また、適切なメカニカルストレングスを有し、膜が設置された部位で物理的な圧力やストレスに耐える能力も重要です。さらに、膜の透過性も考慮される要素であり、栄養素やガスの交換が行えることも求められます。 膜の種類は、主に生分解性膜と非生分解性膜に分類されます。生分解性膜は、体内で時間と共に分解される性質を持ち、通常はポリマーを基にして設計されています。このタイプの膜は、治療後に体内に残ることがないため、特に優れた利点があります。一方、非生分解性膜は、体内に永久に残るものであり、より長期間の支持が必要なケースで用いられます。生分解性膜の例としては、ポリ乳酸（PLA）やポリグリコール酸（PGA）、そしてコラーゲン膜などがあります。これらは、組織再生を促進するための適切な環境を提供しつつ、治癒プロセスに伴って徐々に分解されていきます。 再生誘導膜の用途は多岐にわたりますが、特に歯科領域において重要な役割を果たしています。歯周病によって失われた組織の再生を促す際に、膜が用いられます。また、インプラント治療においては、骨の収縮を防ぐために膜が設置されることがあります。さらに、骨折の治療や骨移植においても、再生誘導膜は重要な役割を持っています。 関連技術としては、組織工学やバイオマテリアルが挙げられます。組織工学は、生体材料と細胞を組み合わせて再生医療の新しい治療法を開発する学問です。再生誘導膜もこの一部として位置づけることができ、細胞の移動や増殖だけでなく、成長因子やサイトカインの使用なども積極的に取り入れられています。これにより、膜の効果がさらに高まることが期待されています。 再生誘導膜を使用することによって、組織再生の過程が効率的に進むだけでなく、患者の回復プロセスを大幅に短縮する可能性があります。これらの技術は、歯科だけでなく、整形外科や外科などの多くの医療分野でも応用されています。 近年では、ナノテクノロジーを取り入れた膜の開発も進んでいます。ナノレベルでの構造制御が可能となることで、膜の特性をさらに向上させることができるため、治療効果の向上が期待されています。さらに、膜に制御放出型の成長因子を組み込むことで、細胞の増殖を促進する新たな手法も開発されています。 総じて、組織＆骨再生誘導用膜は、再生医療および組織工学の進展において重要な役割を果たしており、今後の研究によってさらに多様な応用が期待される分野です。新しい材料や技術の導入によって、より効果的な膜の開発が進み、多くの患者に対して治療の選択肢を広げることが可能になるでしょう。再生医療の未来は明るく、組織再生を促進するための革新的な材料がこれからも登場することを期待しています。 |
